SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-272061
Filing Date
2017-08-29
Accepted
2017-08-29 17:03:57
Documents
4
Period of Report
2017-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d450095d8k.htm 8-K 28272
2 EX-10.1 d450095dex101.htm EX-10.1 94960
3 EX-99.1 d450095dex991.htm EX-99.1 13708
4 GRAPHIC g450095001.jpg GRAPHIC 3741
  Complete submission text file 0001193125-17-272061.txt   143745
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 171058615
SIC: 2834 Pharmaceutical Preparations